Clinical Trials Directory

Trials / Suspended

SuspendedNCT03737695

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

AURORA US: Prospective Biospecimen Repository in Metastatic Breast Cancer

Status
Suspended
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial collects clinical information and tissue and blood samples from patients with breast cancer that has come back or is stage IV. Collecting clinical information and biospecimen samples to create a registry may help doctors better understand the mechanism of tumor spread and determine why people respond differently to specific cancer treatments.

Detailed description

PRIMARY OBJECTIVES: I. To create a comprehensive registry that includes patient demographics, clinical and histopathological data, blood samples, and tissue specimens from the primary tumor and metastatic sites of patients with metastatic breast cancer to improve our understanding of the mechanisms of tumor metastasis and therapeutic resistance. II. To conduct genomic studies of paired primary tumors and distant metastatic sites. III. To conduct genomic studies of paired distant metastatic sites obtained during the course of an individual's disease. IV. To conduct genomic studies of cell free deoxyribonucleic acid (DNA), circulating tumor cell (CTC) derived DNA, germline DNA, and immune based markers in the peripheral circulation. SECONDARY OBJECTIVE: I. To evaluate the concordance between DNA sequencing results obtained from a clinically available assay and those obtained specifically for research purposes. OUTLINE: Patients' archival and newly collected tissue and blood samples are collected periodically for genetic testing. Patients also undergo collection of clinical information within 30 days of biopsy procedure and every 4 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo biospecimen collection
OTHERMedical Chart ReviewUndergo clinical information collection

Timeline

Start date
2019-09-16
Primary completion
2026-09-15
Completion
2029-05-15
First posted
2018-11-09
Last updated
2026-03-18

Locations

14 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03737695. Inclusion in this directory is not an endorsement.